Navigation Links
Clinton, Gates Highlight Treatment, Discrimination of AIDS

Former US president Bill Clinton and Microsoft boss Bill Gates said inadequate access to treatment and continued discrimination were among the biggest problems// in combating the AIDS epidemic, in addresses to the largest ever AIDS conference under way in Toronto.

"We've got to continue to fight the stigma and stop people from being scared to know their status," Clinton told the conference.

Both Clinton and Gates have donated billions of dollars to combat the spread of AIDS through foundations they founded.

In the first full day of the 16th International AIDS Conference, Unicef sought to highlight the plight of children affected by the virus - in particular those orphaned through parents succumbing to AIDS.

Unicef spokeswoman Helga Kuhn told the conference that AIDS orphans were the "problem of the future", as the organisation predicts there will be almost 16 million AIDS orphans by 2010, up from 12 million at the end of 2005.

A new Unicef report highlights the horrendous cycle of infection and poverty that has plagued African countries. Many young children are living with chronically ill parents, forcing them to give up schooling to begin working at very early ages and care for their parents.

Such households continue to spiral further into poverty and are often the subject of discrimination from others in their village, the report says.

Doctors, nurses and teachers are also suffering or dying from the AIDS virus, further affecting health and education services in third-world countries.

Gates called the AIDS epidemic the most "brutal" illness affecting the world. Both Clinton and Gates emphasised the importance of improving access to already existing treatments in third-world countries.

(Source: IANS)
'"/>




Page: 1

Related medicine news :

1. Bill Gates to Fund £28m for Malaria researc
2. Bill Gates Takes Personal Interest in AIDS Program
3. Dr.Tadataka Yamada Designated to open Gates for Global Health Program
4. Gates Foundation to donate USD 104 million to TB Alliance
5. Bill Gates Clarifies that his Decision to Focus on Charity was Personal
6. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
7. Gates Foundation Adopts Fight against Encephalitis
8. $68 million aid pours in from Gates Foundation to fight tropical diseases
9. Gates Foundation Grants $23mn for AIDS programme in India
10. Bill Gates pours in funds for diarrhea treatment reseach
11. Gates Foundation Pledges $3 Million to Fight Malaria in Africa
Post Your Comments:
(Date:10/10/2008)... BEDFORD, Mass., Oct. 10 /PRNewswire-FirstCall/...loper, manufacturer and supplier of premium,diagno...ts dedicated to,serving the healthcare needs of wo...uarter and fiscal 2008 operating results on Tuesda...ction with the release, management will,host a con...
(Date:10/10/2008)... PARK CITY, Utah, Oct. 10 /PRNewswire/ -- NuVie... management of Trace Life Sciences Inc.,(Trace), i...cyclotron,production facilities in Denton, Texas. ... Indium-111, Iodine-123 and Thallium-201 used in,m... NuView Chairman and,CEO, stated that "We are conf...
(Date:10/10/2008)... Coach Holly Warlick Teams Up with Legal and Me...rst-Ever Cancer and Careers Seminar in,Knoxville, ...gnition of National,Breast Cancer Awareness Month,... have joined forces with YWCA Knoxville, The Welln...ocate Holly Warlick, University of Tennessee,women...
(Date:10/10/2008)... The Healthcare Technolog...Care , Exton, PA (PRWEB) ...Valley Chapters of the national Healthcare Informa...ned forces to bring regional health information te...onal conference entitled The Healthcare Technology...
Breaking Medicine News(10 mins):Health News:Hologic, Inc. To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday, November 11, 2008 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2
...erry email devices on its addictive qualities.// ...uld get so addictive that owners might need to be ...hat is similar to that given to drug users. The s...d out by Rutgers University School, in New Jersey,...
...n pounds (Rs.21.94 million) initiative to support ...med at saving one million lives// every year. The... Department for International Development (DFID) i...nse to arrest India's high infant and maternal mor...
...ington D.C. on September 10, 11&12, by Yale School...le and other institutes will// meet to discover ne... neurological disorder that begins in childhood an...vocal tics. The characteristics of TS are blinkin...
...rly 50% of the dentists who joined the health se...f the 2,200 dentists who joined the NHS last year,...were there, according to the NHS Information Centr...n 10 years. There has been a 28% increase in the n...
Other Medicine News:Health News:Conference on developing new treatments for Tourette Syndrome 2Health News:Overseas dentists joining NHS on a high 2
(Date:10/10/2008)...RNewswire/ -- TriReme Medical Inc. (TMI),announced... (Conformite,Europeenne) marking and commercialize...a unique main vessel stent system specially design...resenting the next generation in bifurcation stent... quarter of the 2.2 million,angioplasty procedures...
(Date:10/9/2008)...Institute, Navigenics, Affymetrix and,Microsoft te.... 9 /- A consortium of health care,t...in a first-of-its-kind,research study to assess th... people who choose to receive such screenings to i...n diseases., Sponsored by Scripps Translational S...
(Date:10/8/2008)...rs Research That May Offer New Hope to,Heart Failu...onally, over 3,000 people are,waiting for a heart ...half,of those will receive a transplant. Now, pion...s paving the way for how to treat congestive heart...News Release, go to:, http://www.prnewswire.com/mn...
(Date:10/8/2008)...re/ -- Vical Incorporated (Nasdaq: VICL ),today i...nical data,demonstrating that the company,s Vaxfec...and protein-based infectious disease vaccines and,...harm.D., Ph.D., Vical,s,Senior Vice President of P...ednesday, October 8, at the World Vaccine Congress...
Breaking Medicine Technology:TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5PTC Therapeutics Announces Publication of Preclinical Data in PNAS 1315 1PTC Therapeutics Announces Publication of Preclinical Data in PNAS 1315 2PTC Therapeutics Announces Publication of Preclinical Data in PNAS 1315 3PTC Therapeutics Announces Publication of Preclinical Data in PNAS 1315 41 in 3 Hit Songs Mentions Substance Abuse Smoking 10956 11 in 3 Hit Songs Mentions Substance Abuse Smoking 10956 2FY2009 Budget Increases International Development Funding but Does Little for Domestic Nutrition Programs 10954 1FY2009 Budget Increases International Development Funding but Does Little for Domestic Nutrition Programs 10954 2Successful Clinical Trials and Launch in New Zealand Spurs Phloe to Enter US Market 1313 1Successful Clinical Trials and Launch in New Zealand Spurs Phloe to Enter US Market 1313 2Successful Clinical Trials and Launch in New Zealand Spurs Phloe to Enter US Market 1313 3Successful Clinical Trials and Launch in New Zealand Spurs Phloe to Enter US Market 1313 4Successful Clinical Trials and Launch in New Zealand Spurs Phloe to Enter US Market 1313 5
...th Monoclonal Antibody,Targeting Interleukin-9 (IL...r IL-9 Inhibition in Developing Potential Asthma,T...ire-FirstCall/ --,MedImmune, Inc. today announced ...ess within the company,s inflammatory,disease pipe...studies with its monoclonal antibody (MAb) targeti...
...007 - ARIAD,Pharmaceuticals, Inc. (NASDAQ: ARIA) t...ading cancer centers will present Phase 2 and,1b c...novel mTOR,inhibitor, AP23573, at the annual meeti...SCO) in Chicago, Illinois, on Sunday, June,3, 2007...-agent,AP23573 in patients with soft-tissue and bo...
Other Medicine Technology:MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 2MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 3MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 4MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 5MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 6MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 7Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 2Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 3Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 4
Freedom leg bags are part of the Freedom Urinary Collection Systems: a versatile line of leg bags, kits, and accessories designed to meet the varied needs of our customers. These leg bags are offered
Freedom leg bags are part of the Freedom Urinary Collection Systems: a versatile line of leg bags, kits, and accessories designed to meet the varied needs of our customers. These leg bags are offered
Freedom leg bags are part of the Freedom Urinary Collection Systems: a versatile line of leg bags, kits, and accessories designed to meet the varied needs of our customers. These leg bags are offered
The latex-free, PVC-free Antibacterial Hydro Personal catheter combines two remarkable innovations into one exclusive catheter that delivers an antibacterial agent while providing the virtually frict
Medicine Products: